Boothbay Fund Management, LLC Cidara Therapeutics, Inc. Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$1.25 - $2.35 $44,370 - $83,415	-35,496 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$2.1 - $4.5 $16,197 - $34,708	-7,713 Reduced 17.85%	35,496 $83,000
Q1 2018 May 14, 2018	SELL	$4.0 - $8.15 $45,548 - $92,804	-11,387 Reduced 20.86%	43,209 $173,000
Q4 2017 Feb 14, 2018	BUY	$6.35 - $8.75 $167,043 - $230,177	26,306 Added 92.99%	54,596 $371,000
Q3 2017 Nov 14, 2017	BUY	$5.75 - $8.1 $162,667 - $229,149	28,290	28,290 $229,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.24B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.